|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Debt securities available-for-sale, net of allowance for credit losses ($0 and $0), at fair value (cost: $7,712,847 and $7,714,503) | ||||||||||||||||||||
| Debt securities trading, at fair value (cost: $1,142,723 and $1,204,968) | ||||||||||||||||||||
| Mortgage loans, net of allowance for credit losses ($3,665 and $3,651), ($19,388 and $19,580 at fair value) | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Derivatives, index options | ||||||||||||||||||||
| Equity securities, at fair value (cost: $14,229 and $14,268) | ||||||||||||||||||||
| Other long-term investments | ||||||||||||||||||||
| Short-term investments, at fair value | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Deferred sales inducements | ||||||||||||||||||||
| Value of business acquired | ||||||||||||||||||||
| Cost of reinsurance | ||||||||||||||||||||
| Market risk benefits asset, at fair value | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Federal income tax receivable | ||||||||||||||||||||
| Deferred federal income tax asset (Note 1) | ||||||||||||||||||||
| Amounts recoverable from reinsurer | ||||||||||||||||||||
| Amounts recoverable from reinsurer, net of allowance for credit losses ($0 and $0) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Future policyholder obligations: | ||||||||||||||||||||
| Universal life and annuity contracts | ||||||||||||||||||||
| Liability for policyholder account balances | ||||||||||||||||||||
| Additional liability for benefits in excess of account balance | ||||||||||||||||||||
| Liability for future policy benefits | ||||||||||||||||||||
| Market risk benefits liability, at fair value | ||||||||||||||||||||
| Other policyholder liabilities | ||||||||||||||||||||
| Funds withheld liability | ||||||||||||||||||||
| Deferred Federal income tax liability | ||||||||||||||||||||
| Federal income tax payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Common stock: | ||||||||||||||||||||
| Common stock value | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Mortgage loans-allowance for possible losses | ||||||||||||||||||||
Loading...
